Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
This prospective, randomized, controlled, multi-center clinical trial will evaluate the effect and security of reh-acteoside therapy for patients of IgA nephropathy.
Epistemonikos ID: 776cae034d14810e61e5746c86700c974007d571
First added on: Dec 20, 2022